Insider · CIK 0001448698
Charles Cherington
owner
Files at ERNA (Ernexa Therapeutics Inc.). First filing Apr 4, 2025, latest Jun 11, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
2 / 0
$2.6M bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 47Moderate | ERNAbuy Ernexa Therapeutics Inc. | $2.2M 21,241,163 shares | +104% | - | |
| 29Weak | ERNAbuy Ernexa Therapeutics Inc. | $394k 3,768,397 shares | +23% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 9, 2025 | ERNA Ernexa Therapeutics Inc. | POpen-market purchase Common Stock | +21,241,163 | $0.10 | $2.2M | 41,659,743 | Jun 11, 2025 |
| Sep 24, 2024 | ERNA Ernexa Therapeutics Inc. | POpen-market purchase Common Stock | +261,756 | - | - | 818,221 | May 7, 2025 |
| Sep 24, 2024 | ERNA Ernexa Therapeutics Inc. | POpen-market purchase Common Stock | +4,768,783 | - | - | 5,587,004 | May 7, 2025 |
| Sep 24, 2024 | ERNA Ernexa Therapeutics Inc. | POpen-market purchase Common Stock | +1,237,762 | - | - | 6,824,766 | May 7, 2025 |
| Sep 24, 2024 | ERNA Ernexa Therapeutics Inc. | POpen-market purchase Common Stock | +5,420,823 | - | - | 12,245,589 | May 7, 2025 |
| Sep 24, 2024 | ERNA Ernexa Therapeutics Inc. | POpen-market purchase Common Stock | +1,562,988 | - | - | 13,808,577 | May 7, 2025 |
| Sep 24, 2024 | ERNA Ernexa Therapeutics Inc. | SOpen-market sale 12.0% Senior Convertible Notes due December 12, 2028derivative | - | - | - | 0 | May 7, 2025 |
| Sep 24, 2024 | ERNA Ernexa Therapeutics Inc. | SOpen-market sale 6.0% Senior Convertible Promissory Notes due 2028derivative | - | - | - | 0 | May 7, 2025 |
| Sep 24, 2024 | ERNA Ernexa Therapeutics Inc. | SOpen-market sale Warrants (right to buy)derivative | -523,512 | - | - | 0 | May 7, 2025 |
| Sep 24, 2024 | ERNA Ernexa Therapeutics Inc. | SOpen-market sale Warrants (right to buy)derivative | -2,475,524 | - | - | 0 | May 7, 2025 |
| Sep 24, 2024 | ERNA Ernexa Therapeutics Inc. | SOpen-market sale Warrants (right to buy)derivative | -3,125,976 | - | - | 0 | May 7, 2025 |
| Apr 2, 2025 | ERNA Ernexa Therapeutics Inc. | POpen-market purchase Common Stock | +3,768,397 | $0.10 | $394k | 20,401,602 | Apr 4, 2025 |
| Oct 29, 2024 | ERNA Ernexa Therapeutics Inc. | POpen-market purchase Common Stock | +261,756 | - | - | 818,221 | Nov 5, 2024 |
| Oct 29, 2024 | ERNA Ernexa Therapeutics Inc. | POpen-market purchase Common Stock | +4,768,783 | - | - | 5,587,004 | Nov 5, 2024 |
| Oct 29, 2024 | ERNA Ernexa Therapeutics Inc. | POpen-market purchase Common Stock | +1,237,762 | - | - | 6,824,766 | Nov 5, 2024 |
| Oct 29, 2024 | ERNA Ernexa Therapeutics Inc. | POpen-market purchase Common Stock | +5,420,823 | - | - | 12,245,589 | Nov 5, 2024 |
| Oct 29, 2024 | ERNA Ernexa Therapeutics Inc. | POpen-market purchase Common Stock | +1,562,988 | - | - | 13,808,577 | Nov 5, 2024 |
| Oct 29, 2024 | ERNA Ernexa Therapeutics Inc. | CConversion Common Stock | +2,819,546 | $0.50 | $1.4M | 16,628,123 | Nov 5, 2024 |
| Sep 23, 2024 | ERNA Ernexa Therapeutics Inc. | POpen-market purchase 6.0% Senior Convertible Promissory Notes due 2028derivative | - | - | - | - | Nov 5, 2024 |
| Sep 23, 2024 | ERNA Ernexa Therapeutics Inc. | POpen-market purchase Warrants (right to buy)derivative | +83,916 | - | - | 2,391,608 | Nov 5, 2024 |
| Sep 23, 2024 | ERNA Ernexa Therapeutics Inc. | POpen-market purchase 6.0% Senior Convertible Promissory Notes due 2028derivative | - | - | - | - | Nov 5, 2024 |
| Sep 23, 2024 | ERNA Ernexa Therapeutics Inc. | POpen-market purchase Warrants (right to buy)derivative | +83,916 | - | - | 2,475,524 | Nov 5, 2024 |
| Sep 24, 2024 | ERNA Ernexa Therapeutics Inc. | POpen-market purchase 12.0% Senior Convertible Notes due September 24, 2025derivative | - | $1,368,626.00 | - | - | Nov 5, 2024 |
| Oct 29, 2024 | ERNA Ernexa Therapeutics Inc. | CConversion 12.0% Senior Convertible Notes due September 24, 2025derivative | - | $0.00 | - | 0 | Nov 5, 2024 |
| Oct 29, 2024 | ERNA Ernexa Therapeutics Inc. | SOpen-market sale 12.0% Senior Convertible Notes due December 12, 2028derivative | - | - | - | 0 | Nov 5, 2024 |
| Oct 29, 2024 | ERNA Ernexa Therapeutics Inc. | SOpen-market sale 6.0% Senior Convertible Promissory Notes due 2028derivative | - | - | - | 0 | Nov 5, 2024 |
| Oct 29, 2024 | ERNA Ernexa Therapeutics Inc. | SOpen-market sale Warrants (right to buy)derivative | -523,512 | - | - | 0 | Nov 5, 2024 |
| Oct 29, 2024 | ERNA Ernexa Therapeutics Inc. | SOpen-market sale Warrants (right to buy)derivative | -2,475,524 | - | - | 0 | Nov 5, 2024 |
| Oct 29, 2024 | ERNA Ernexa Therapeutics Inc. | SOpen-market sale Warrants (right to buy)derivative | -3,125,976 | - | - | 0 | Nov 5, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.